Captrust Financial Advisors Cytom X Therapeutics, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$1.53 - $2.89 $1,124 - $2,124	-735 Reduced 63.14%	429 $1,000
Q1 2022 May 16, 2022	BUY	$2.67 - $4.68 $437 - $767	164 Added 16.4%	1,164 $3,000
Q2 2021 Aug 16, 2021	BUY	$6.33 - $9.91 $1,899 - $2,973	300 Added 42.86%	1,000 $6,000
Q1 2021 May 17, 2021	BUY	$6.6 - $9.0 $4,620 - $6,300	700 New	700 $5,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.